What makes the mitochondria a killer? Can we condition them to be less destructive?

  title={What makes the mitochondria a killer? Can we condition them to be less destructive?},
  author={Elizabeth Murphy and Charles Jr Steenbergen},
  journal={Biochimica et biophysica acta},
  volume={1813 7},

Figures and Tables from this paper

Role of Mitochondrial Calcium and the Permeability Transition Pore in Regulating Cell Death.

This review will critically evaluate the candidates for the pore-forming unit of the PTP and discuss recent data suggesting that assumption that the P TP is formed by a single molecular identity may need to be reconsidered.

Role of Mitochondria in Ischemia and Cardioprotection

Key factors linking mitochondrial dysfunction to myocardial injury have been studied along with potential protective mechanisms elicited by endogenous processes and pharmacological treatments, and a reduced rate of ATP hydrolysis and a slight increase in reactive oxygen species (ROS) formation appear to represent the prevailing components of self-defense mechanisms.


The pharmacological strategy inhibiting mitochondrial outer membrane permeability and thus apoptosis, by manipulation of the Bcl-2 family proteins and Mitochondrial Permeability Transition Pore to protect the myocardium against ischemia-reperfusion has already provided interesting results, which support the idea that a clinical benefit might be obtained in the near future.

Mitochondrial pharmacology.

Mitochondrial dynamics: an emerging paradigm in ischemia-reperfusion injury.

The aims in this review are to provide a synopsis of the molecular mechanisms of fission and fusion, summarize the current understanding of the complex relationships between mitochondrial dynamics and the pathogenesis of ischemia-reperfusion injury, and speculate on the possibility that targeted manipulation of mitochondrial dynamics may be exploited for the design of novel therapeutic strategies for cardio- and neuroprotection.

PUMA-mediated mitochondrial apoptotic disruption by hypoxic postconditioning

The data suggest that reduction of PUMA expression mediates the endogenous cardioprotective mechanisms of postconditioning by disrupting mitochondrial apoptotic pathway.

Mitochondria in Cardiac Postconditioning

The aim of the present mini-review is to discuss in a historical perspective the role of main mitochondria mechanisms in cardiac postconditioning.

Using chemical biology to assess and modulate mitochondria: progress and challenges

The application of interdisciplinary approaches at the interface between chemistry and biology are opening up new opportunities to understand mitochondrial function and in assessing the role of the organelle in biology, leading to the development of new classes of therapies.

Fmr1 protects cardiomyocytes against lipopolysaccharide-induced myocardial injury

Fmr1 overexpression alleviated oxidative stress and apoptosis in H9c2 cardiomyocytes injured by LPS via regulating oxidative stress, apoptosis-associated factors, as well as the PI3K/Akt pathway.



Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death

The results indicate that the CypD-dependent mPT regulates some forms of necrotic death, but not apoptotic death, as indicated by resistance to ischaemia/reperfusion-induced cardiac injury.

Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury.

Emerging evidence indicates that NO can directly act on mitochondria, independent of the sGC pathway, affording acute cardioprotection against IR injury.

Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death

Cyclophilin D and the mitochondrial permeability transition are required for mediating Ca2+- and oxidative damage-induced cell death, but not Bcl-2 family member-regulated death.

Mitochondrial K(ATP) channels in cell survival and death.

Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Preconditioning activates a number of signaling pathways that reduce Ca(2+) overload and reduce activation of the mitochondrial permeability transition pore, and reducing ROS have both been reported to reduce ischemic injury.

Role of Glycogen Synthase Kinase-3β in Cardioprotection

Gaining a better understanding of these interactions to control and prevent mPTP induction when appropriate will enable to decrease the negative impact of the reperfusion-induced ROS burst on the fate of mitochondria and perhaps allow to limit propagation of damage throughout and between cells and consequently, to better limit infarct size.

Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore

It is shown that reoxygenation after prolonged hypoxia reduces the reactive oxygen species (ROS) threshold for the mitochondrial permeability transition (MPT) in cardiomyocytes and that cell survival is steeply negatively correlated with the fraction of depolarized mitochondria.